Allergan PLC (AGN)

245.72
1.40 0.56
NYSE : Health Care
Prev Close 247.11
Open 247.23
Day Low/High 245.02 / 247.93
52 Wk Low/High 184.50 / 261.27
Volume 1.73M
Avg Volume 2.27M
Exchange NYSE
Shares Outstanding 335.87M
Market Cap 82.08B
EPS 38.20
P/E Ratio N/A
Div & Yield 2.80 (1.10%)

Latest News

Cramer: If There's No Reason for a Rally, Then Something's Wrong

Cramer: If There's No Reason for a Rally, Then Something's Wrong

I think caution is warranted if we rally again like this.

Allergan Is Putting the Bull Back in Charge

Allergan Is Putting the Bull Back in Charge

Prices have rallied since late May.

All the Rallying Big Bank Stocks Look Very Risky, Doug Kass Says

All the Rallying Big Bank Stocks Look Very Risky, Doug Kass Says

Doug Kass shares his thoughts on Apple, Google and Starbucks.

Weekly Roundup

Tech rotation, oil and Fed rate hike keep markets on even (make that flat) keel. Several portfolio positions get beefed up.

Opioid Marketing Under Bipartisan Investigation

Opioid Marketing Under Bipartisan Investigation

Individual state investigations of opioid marketing practices has lead to a multistate investigation of the prescription painkiller industry.

Why Alexion's Gain In the C-Suite Doesn't Bode Well For Biogen Takeout Prospects

Why Alexion's Gain In the C-Suite Doesn't Bode Well For Biogen Takeout Prospects

Paul Clancy's move to another biotech firm could mean that there's nothing imminent in terms of Biogen being bought out, says Mizuho analyst Salim Syed.

Cramer: You Need 2 Monday Morning Game Plans

Cramer: You Need 2 Monday Morning Game Plans

We really want to shake out the weak hands here.

Weekly Roundup

After a busy Thursday, markets look forward to economic data and the Fed meeting next week. In the portfolio, we dropped a tech stock and added a healthcare name.

Remember the Rules of the Road

Remember the Rules of the Road

Diversification is the only risk management strategy that will work consistently.

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.

Allergan To Acquire Keller Medical, Inc., Adding Keller FunnelĀ® To Company's Leading Plastic Surgery Portfolio

- Funnel Provides Novel, No-Touch Breast Implant Insertion Device for Plastic Surgeons -

Cramer: 15 Stocks to Buy for the Triathlon of Fear Coming on Super-Thursday

Cramer: 15 Stocks to Buy for the Triathlon of Fear Coming on Super-Thursday

The handwringers will be out in full force. Their fear creates buying opportunities.

Weekly Roundup

Stocks start to recover from recent setbacks. Portfolio moves include a tech-stock downgrade.

Small-Cap Action Is Improving

Small-Cap Action Is Improving

But I don't have a lot of confidence in this market beyond the intraday action.

Uber's Quarterly Loss was a Staggering $708 Million, Key Exec Leaves

Uber's Quarterly Loss was a Staggering $708 Million, Key Exec Leaves

Uber's first quarter loss was less than the $991 million loss reported 3 months ago.

Ohio Going After Drug Makers for Fueling Opioid Crisis

Ohio Going After Drug Makers for Fueling Opioid Crisis

Ohio Attorney General Mike DeWine claims the companies weren't honest with doctors about the risks associated with the painkillers.

Takeaways and Observations; Deep Thoughts: Doug Kass' Views

Takeaways and Observations; Deep Thoughts: Doug Kass' Views

Doug Kass shares his thoughts on the market, and offers up some especially deep thoughts.

The Good, the Bad and the Ugly; Explaining the Inexplicable: Doug Kass' Views

The Good, the Bad and the Ugly; Explaining the Inexplicable: Doug Kass' Views

Doug Kass shares his thoughts on trying to explain that which cannot be explained, and also discusses what was good (and bad and ugly) this week.

Weekly Roundup

Markets rebound amid headlines about oil, Trump and other news. Portfolio moves include an airline downgrade.

Shark Bites: Focus on the 'Little Picture'

Shark Bites: Focus on the 'Little Picture'

Here's what I'm trading today amid the 'flat with a positive tone' action.

Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADEā„¢ (Oxymetazoline HCL) Cream, 1%

REKNOWNED ACTRESS AND SINGER TO HOST LAUNCH EVENT TO RAISE AWARENESS OF NEW TREATMENT FOR PERSISTENT FACIAL REDNESS ASSOCIATED WITH ROSACEA(1)

Has Allergan's Pullback Run Its Course?

Has Allergan's Pullback Run Its Course?

We make our case.

There You Have It; The Day's Trades: Doug Kass' Views

There You Have It; The Day's Trades: Doug Kass' Views

Doug Kass shares his thoughts on whether there's any there, there, and reveals some recent trades.